CDMO News
Kaneka Eurogentec’s New GMP mRNA Facility Now Ready for Vaccine and Gene Therapy Production
Kaneka Eurogentec, a CDMO inspected by both the FDA and EMA, has secured regulatory accreditation for its new good manufacturing practice (GMP) facility dedicated to mRNA production. This expansion strengthens its position in contract manufacturing services for advanced therapies and
1 July 2025